Ultrasound Conductivity Gels Market: Diagnostic Centers to Give a Cut-throat Competition to Hospitals and Clinics with Growing Technological Advancements: Global Industry Analysis (2013 - 2017) & Opportunity Assessment (2018 - 2028)
The use of ultrasound conductivity gels is incessantly across the globe with government support and healthcare expenditure increasing. Government try to minimize the infant and maternal mortality rate employing different schemes and moreover, high population growth and flourishing economy are key dynamics bolstering growth of ultrasound procedures which increase the demand for ultrasound conductivity gels in the global market. The government is employing different schemes for reduction in maternal and infant mortality rate. For instance, Central schemes in India such as the Janani Suraksha Yojna has been launch by government of India so that the women in rural areas can take advantage of professional medical care during prenatal period and have deliveries in hospitals and primary health care centers rather than at home.
Moreover, the increase in the deployment of diagnostic ultrasound procedures has been due in part to technological advances, which have improved the quality of ultrasound images and physicians' aptitude to engage them to diagnose medical conditions. Technological advancements have also resulted in the development of ultrasound devices which are lesser and more portable. The better portability of ultrasound equipment has made it easier for beneficiaries to receive ultrasound exams in skilled nursing facilities (SNF) which further surges the demand for ultrasound procedures and gels.
Clinics are expected to dominate the market in terms of use of ultrasound conductivity gels over the course of the forecast period
The use of ultrasound conductivity gels is comparatively high in clinics as compared to any other healthcare unit as the patients coming for these procedures and the number of procedures taking place is comparatively high here. Ultrasound scanning is considered as an important technology used in emergency wards, intensive care units, operating room and in prenatal conditions to deliver correct patient care. The increasing awareness in early diagnosis and treatment of disease and increase in the number of clinics and diagnostic centers will further increases the demand for ultrasound procedures and boost the need for ultrasound gels globally. The demand for ultrasound gels is also relatively high in middle-income or developing countries as the prevalence of hospitals in these areas is less as compared to that of clinics. Clinics also do not use any substitute and stuck to the status quo in terms of experimenting with ultrasound conductivity gels.
Hospitals and diagnostics centers are gearing up in the adoption of this procedure as well as these ultrasound conductivity gels
Hospitals are expected to foresee comparatively extensive growth owing to the burgeoning demand for ultrasound procedures and also due to developing infrastructure across the globe. Ultrasound conductive gels are used in ultrasound procedures for diagnosis and therapeutic treatment. The gel is applied at the beginning of ultrasound scan. It is also utilized with fetal Doppler to hear heartbeat of an unborn child. Currently, ultrasound technology is generally used in many hospitals and healthcare other facilities.
Additionally, the surge in the employment of ultrasound scanning in rural and remote areas due to its portability, availability, low cost and durability will increase the demand of ultrasound conductivity gels in low and middle cost income countries. As ultrasound is most effective in limited healthcare resources, in past few decades, the ultrasound is gaining traction as a valuable imaging technology and helps in driving the diagnostic ability of hospitals in rural, resource limited countries.
- 1. Executive Summary
- 1.1. Market Overview
- 1.2. Market Analysis
- 1.3. FMI Analysis and Recommendations
- 1.4. Wheel of Fortune
- 2. Market Introduction
- 2.1. Market Taxonomy
- 2.2. Market Definition
- 3. Global Economic Outlook
- 3.1. Global Healthcare Market Outlook by Region
- 4. Ultrasound Conductivity Gels Market Overview
- 4.1. Key Manufacturer List
- 4.2. Key Distributors List
- 4.3. Market Dynamics Impact Analysis
- 4.4. Comparative Analysis
- 4.5. Pricing Analysis
- 5. Ultrasound Conductivity Gels Market View Point Analysis
- 5.1. Macro-Economic Factors
- 5.2. Market Drivers
- 5.3. Market Restraints
- 5.4. Opportunity Analysis
- 5.5. Market Trends
- 6. North America Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 6.1. Introduction
- 6.2. Historical Market Size (US$ Mn) By Country, 2013-2017
- 6.2.1. U.S.
- 6.2.2. Canada
- 6.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 6.4.1. Sterile Gels
- 6.4.2. Non Sterile Gels
- 6.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 6.5.1. Sterile Gels
- 6.5.2. Non Sterile Gels
- 6.6. Historical Market Size (US$ Mn) By End User, 2013-2017
- 6.6.1. Hospitals
- 6.6.2. Clinics
- 6.6.3. Diagnostic Centers
- 6.6.4. Ambulatory Surgical Centers
- 6.7. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 6.7.1. Hospitals
- 6.7.2. Clinics
- 6.7.3. Diagnostic Centers
- 6.7.4. Ambulatory Surgical Centers
- 6.8. Market Attractiveness Analysis
- 6.8.1. By Country
- 6.8.2. By Product Type
- 6.8.3. By End User
- 6.9. Drivers and Restraints: Impact Analysis
- 6.10. Key Participants Market Presence (Intensity Map)
- 6.11. Ultrasound Conductivity Gels Market Snapshot
- 7. Latin America Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 7.1. Introduction
- 7.2. Historical Market Size (US$ Mn) By Country, 2013-2017
- 7.2.1. Brazil
- 7.2.2. Mexico
- 7.2.3. Rest of Latin America
- 7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
- 7.3.1. Brazil
- 7.3.2. Mexico
- 7.3.3. Rest of Latin America
- 7.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 7.4.1. Sterile Gels
- 7.4.2. Non Sterile Gels
- 7.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 7.5.1. Sterile Gels
- 7.5.2. Non Sterile Gels
- 7.6. Historical Market Size (US$ Mn) By End User, 2013-2017
- 7.6.1. Hospitals
- 7.6.2. Clinics
- 7.6.3. Diagnostic Centers
- 7.6.4. Ambulatory Surgical Centers
- 7.7. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 7.7.1. Hospitals
- 7.7.2. Clinics
- 7.7.3. Diagnostic Centers
- 7.7.4. Ambulatory Surgical Centers
- 7.8. Market Attractiveness Analysis
- 7.8.1. By Country
- 7.8.2. By Product Type
- 7.8.3. By End User
- 7.9. Drivers and Restraints: Impact Analysis
- 7.10. Key Participants Market Presence (Intensity Map)
- 7.11. Ultrasound Conductivity Gels Market Snapshot
- 8. Western Europe Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 8.1. Introduction
- 8.2. Historical Market Size (US$ Mn) By Country, 2013-2017
- 8.2.1. United Kingdom
- 8.2.2. France
- 8.2.3. Germany
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Rest of Western Europe
- 8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
- 8.3.1. United Kingdom
- 8.3.2. France
- 8.3.3. Germany
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Rest of Western Europe
- 8.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 8.4.1. Sterile Gels
- 8.4.2. Non Sterile Gels
- 8.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 8.5.1. Sterile Gels
- 8.5.2. Non Sterile Gels
- 8.6. Historical Market Size (US$ Mn) By End User, 2013-2017
- 8.6.1. Hospitals
- 8.6.2. Clinics
- 8.6.3. Diagnostic Centers
- 8.6.4. Ambulatory Surgical Centers
- 8.7. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 8.7.1. Hospitals
- 8.7.2. Clinics
- 8.7.3. Diagnostic Centers
- 8.7.4. Ambulatory Surgical Centers
- 8.8. Market Attractiveness Analysis
- 8.8.1. By Country
- 8.8.2. By Product Type
- 8.8.3. By End User
- 8.9. Drivers and Restraints: Impact Analysis
- 8.10. Key Participants Market Presence (Intensity Map)
- 8.11. Ultrasound Conductivity Gels Market Snapshot
- 9. Eastern Europe Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 9.1. Introduction
- 9.2. Historical Market Size (US$ Mn) By Country, 2013-2017
- 9.2.1. Russia
- 9.2.2. Poland
- 9.2.3. Rest of Eastern Europe
- 9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
- 9.3.1. Russia
- 9.3.2. Poland
- 9.3.3. Rest of Eastern Europe
- 9.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 9.4.1. Sterile Gels
- 9.4.2. Non Sterile Gels
- 9.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 9.5.1. Sterile Gels
- 9.5.2. Non Sterile Gels
- 9.6. Historical Market Size (US$ Mn) By End User, 2013-2017
- 9.6.1. Hospitals
- 9.6.2. Clinics
- 9.6.3. Diagnostic Centers
- 9.6.4. Ambulatory Surgical Centers
- 9.7. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 9.7.1. Hospitals
- 9.7.2. Clinics
- 9.7.3. Diagnostic Centers
- 9.7.4. Ambulatory Surgical Centers
- 9.8. Market Attractiveness Analysis
- 9.8.1. By Country
- 9.8.2. By Product Type
- 9.8.3. By End User
- 9.9. Drivers and Restraints: Impact Analysis
- 9.10. Key Participants Market Presence (Intensity Map)
- 9.11. Ultrasound Conductivity Gels Market Snapshot
- 10. Asia Pacific Excluding China and Japan Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Mn) By Country, 2013-2017
- 10.2.1. India
- 10.2.2. Australia and New Zealand
- 10.2.3. ASEAN
- 10.2.4. Rest of APECJ
- 10.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
- 10.3.1. India
- 10.3.2. Australia and New Zealand
- 10.3.3. ASEAN
- 10.3.4. Rest of APECJ
- 10.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 10.4.1. Sterile Gels
- 10.4.2. Non Sterile Gels
- 10.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 10.5.1. Sterile Gels
- 10.5.2. Non Sterile Gels
- 10.6. Historical Market Size (US$ Mn) By End User, 2013-2017
- 10.6.1. Hospitals
- 10.6.2. Clinics
- 10.6.3. Diagnostic Centers
- 10.6.4. Ambulatory Surgical Centers
- 10.7. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 10.7.1. Hospitals
- 10.7.2. Clinics
- 10.7.3. Diagnostic Centers
- 10.7.4. Ambulatory Surgical Centers
- 10.8. Market Attractiveness Analysis
- 10.8.1. By Country
- 10.8.2. By Product Type
- 10.8.3. By End User
- 10.9. Drivers and Restraints: Impact Analysis
- 10.10. Key Participants Market Presence (Intensity Map)
- 10.11. Ultrasound Conductivity Gels Market Snapshot
- 11. China Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 11.2.1. Sterile Gels
- 11.2.2. Non Sterile Gels
- 11.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 11.3.1. Sterile Gels
- 11.3.2. Non Sterile Gels
- 11.4. Historical Market Size (US$ Mn) By End User, 2013-2017
- 11.4.1. Hospitals
- 11.4.2. Clinics
- 11.4.3. Diagnostic Centers
- 11.4.4. Ambulatory Surgical Centers
- 11.5. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 11.5.1. Hospitals
- 11.5.2. Clinics
- 11.5.3. Diagnostic Centers
- 11.5.4. Ambulatory Surgical Centers
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product Type
- 11.6.2. By End User
- 11.7. Drivers and Restraints: Impact Analysis
- 11.8. Key Participants Market Presence (Intensity Map)
- 11.9. Ultrasound Conductivity Gels Market Snapshot
- 12. Japan Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 12.2.1. Sterile Gels
- 12.2.2. Non Sterile Gels
- 12.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 12.3.1. Sterile Gels
- 12.3.2. Non Sterile Gels
- 12.4. Historical Market Size (US$ Mn) By End User, 2013-2017
- 12.4.1. Hospitals
- 12.4.2. Clinics
- 12.4.3. Diagnostic Centers
- 12.4.4. Ambulatory Surgical Centers
- 12.5. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 12.5.1. Hospitals
- 12.5.2. Clinics
- 12.5.3. Diagnostic Centers
- 12.5.4. Ambulatory Surgical Centers
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product Type
- 12.6.2. By End User
- 12.7. Drivers and Restraints: Impact Analysis
- 12.8. Key Participants Market Presence (Intensity Map)
- 12.9. Ultrasound Conductivity Gels Market Snapshot
- 13. Middle East and Africa Ultrasound Conductivity Gels Market Analysis 2013–2017 and Forecast 2018–2028
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) By Country, 2013-2017
- 13.2.1. GCC Countries
- 13.2.2. South Africa
- 13.2.3. Rest of Middle East and Africa
- 13.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
- 13.3.1. GCC Countries
- 13.3.2. South Africa
- 13.3.3. Rest of Middle East and Africa
- 13.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
- 13.4.1. Sterile Gels
- 13.4.2. Non Sterile Gels
- 13.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
- 13.5.1. Sterile Gels
- 13.5.2. Non Sterile Gels
- 13.6. Historical Market Size (US$ Mn) By End User, 2013-2017
- 13.6.1. Hospitals
- 13.6.2. Clinics
- 13.6.3. Diagnostic Centers
- 13.6.4. Ambulatory Surgical Centers
- 13.7. Market Size (US$ Mn) Forecast By End User, 2018-2028
- 13.7.1. Hospitals
- 13.7.2. Clinics
- 13.7.3. Diagnostic Centers
- 13.7.4. Ambulatory Surgical Centers
- 13.8. Market Attractiveness Analysis
- 13.8.1. By Country
- 13.8.2. By Product Type
- 13.8.3. By End User
- 13.9. Drivers and Restraints: Impact Analysis
- 13.10. Key Participants Market Presence (Intensity Map)
- 13.11. Ultrasound Conductivity Gels Market Snapshot
- 14. Forecast Factors: Relevance and Impact
- 15. Forecast Assumptions
- 16. Competition Landscape
- 16.1. Competition Dashboard
- 16.2. Co Company Deep Dive
- 16.2.1. Medline Industries Inc.
- 16.2.1.1. Overview
- 16.2.1.2. Product and Age Group Portfolio
- 16.2.1.3. Production Footprint
- 16.2.1.4. Sales Footprint
- 16.2.1.5. Channel Footprint
- 16.2.1.6. Strategy
- 16.2.1.6.1.1. Marketing Strategy
- 16.2.1.6.1.2. Product Strategy
- 16.2.1.6.1.3. Channel Strategy
- 16.2.2. Parker Laboratories, Inc.
- 16.2.2.1. Overview
- 16.2.2.2. Product and Age Group Portfolio
- 16.2.2.3. Production Footprint
- 16.2.2.4. Sales Footprint
- 16.2.2.5. Channel Footprint
- 16.2.2.6. Strategy
- 16.2.2.6.1.1. Marketing Strategy
- 16.2.2.6.1.2. Product Strategy
- 16.2.2.6.1.3. Channel Strategy
- 16.2.3. Roscoe Medical
- 16.2.3.1. Overview
- 16.2.3.2. Product and Age Group Portfolio
- 16.2.3.3. Production Footprint
- 16.2.3.4. Sales Footprint
- 16.2.3.5. Channel Footprint
- 16.2.3.6. Strategy
- 16.2.3.6.1. Marketing Strategy
- 16.2.3.6.2. Product Strategy
- 16.2.3.6.3. Channel Strategy
- 16.2.4. Cardinal Health, Inc.
- 16.2.4.1. Overview
- 16.2.4.2. Product and Age Group Portfolio
- 16.2.4.3. Production Footprint
- 16.2.4.4. Sales Footprint
- 16.2.4.5. Channel Footprint
- 16.2.4.6. Strategy
- 16.2.4.6.1. Marketing Strategy
- 16.2.4.6.2. Product Strategy
- 16.2.4.6.3. Channel Strategy
- 16.2.5. Eco-Med Diagnostic Imaging
- 16.2.5.1. Overview
- 16.2.5.2. Product and Age Group Portfolio
- 16.2.5.3. Production Footprint
- 16.2.5.4. Sales Footprint
- 16.2.5.5. Channel Footprint
- 16.2.5.6. Strategy
- 16.2.5.6.1. Marketing Strategy
- 16.2.5.6.2. Product Strategy
- 16.2.5.6.3. Channel Strategy
- 16.2.6. National Therapy Products Inc.
- 16.2.6.1. Overview
- 16.2.6.2. Product and Age Group Portfolio
- 16.2.6.3. Production Footprint
- 16.2.6.4. Sales Footprint
- 16.2.6.5. Channel Footprint
- 16.2.6.6. Strategy
- 16.2.6.6.1. Marketing Strategy
- 16.2.6.6.2. Product Strategy
- 16.2.6.6.3. Channel Strategy
- 16.2.7. Modul Diagram Srl
- 16.2.7.1. Overview
- 16.2.7.2. Product and Age Group Portfolio
- 16.2.7.3. Production Footprint
- 16.2.7.4. Sales Footprint
- 16.2.7.5. Channel Footprint
- 16.2.7.6. Strategy
- 16.2.7.6.1. Marketing Strategy
- 16.2.7.6.2. Product Strategy
- 16.2.7.6.3. Channel Strategy
- 16.2.8. Ceracarta Spa
- 16.2.8.1. Overview
- 16.2.8.2. Product and Age Group Portfolio
- 16.2.8.3. Production Footprint
- 16.2.8.4. Sales Footprint
- 16.2.8.5. Channel Footprint
- 16.2.8.6. Strategy
- 16.2.8.6.1. Marketing Strategy
- 16.2.8.6.2. Product Strategy
- 16.2.8.6.3. Channel Strategy
- 16.2.9. DJO Global, Inc.
- 16.2.9.1. Overview
- 16.2.9.2. Product and Age Group Portfolio
- 16.2.9.3. Production Footprint
- 16.2.9.4. Sales Footprint
- 16.2.9.5. Channel Footprint
- 16.2.9.6. Strategy
- 16.2.9.6.1. Marketing Strategy
- 16.2.9.6.2. Product Strategy
- 16.2.9.6.3. Channel Strategy
- 16.2.10. Pharmaceutical Innovation Inc.
- 16.2.10.1. Overview
- 16.2.10.2. Product and Age Group Portfolio
- 16.2.10.3. Production Footprint
- 16.2.10.4. Sales Footprint
- 16.2.10.5. Channel Footprint